88697269 - SALMET-VEC

Information

  • Trademark
  • 88697269
  • Serial Number
    88697269
  • Registration Number
    6429133
  • Filing Date
    November 18, 2019
    5 years ago
  • Registration Date
    July 20, 2021
    3 years ago
  • Transaction Date
    December 08, 2021
    3 years ago
  • Status Date
    July 20, 2021
    3 years ago
  • Published for Opposition Date
    May 12, 2020
    4 years ago
  • Location Date
    June 14, 2021
    3 years ago
  • First Use Anywhere Date
    November 12, 2020
    4 years ago
  • First Use In Commerce Date
    November 12, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LAWRENCE, SUSAN KASTRI
  • Attorney Name
    Kevin O'Keefe
    Law Office Assigned Location Code
    M70
  • Owners
Mark Drawing Code
4000
Mark Identification
SALMET-VEC
Case File Statements
  • GS0051: Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Protein arrays for diagnosing cancer; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Tumor suppressing agents; all containing in whole or significant part, gene therapy substances
  • PM0001: SAL MET-VEC
  • TR0010: The wording "SALMET-VEC" has no meaning in a foreign language.
Case File Event Statements
  • 12/7/2021 - 3 years ago
    31 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 12/7/2021 - 3 years ago
    30 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 12/7/2021 - 3 years ago
    29 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/20/2021 - 3 years ago
    28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/15/2021 - 3 years ago
    27 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 6/14/2021 - 3 years ago
    26 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 6/11/2021 - 3 years ago
    25 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/11/2021 - 3 years ago
    24 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/11/2021 - 3 years ago
    23 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/2/2021 - 3 years ago
    22 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/2/2021 - 3 years ago
    21 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/2/2021 - 3 years ago
    20 - SU - NON-FINAL ACTION - WRITTEN Type: CNRT
  • 1/26/2021 - 3 years ago
    19 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 1/6/2021 - 3 years ago
    18 - USE AMENDMENT FILED Type: IUAF
  • 1/26/2021 - 3 years ago
    17 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 1/6/2021 - 3 years ago
    16 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 7/7/2020 - 4 years ago
    15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/12/2020 - 4 years ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/12/2020 - 4 years ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/22/2020 - 4 years ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/3/2020 - 4 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/3/2020 - 4 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/3/2020 - 4 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/1/2020 - 4 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 3/25/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/22/2020 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/22/2020 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/22/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/20/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/25/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 11/21/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP